Divis Laboratories
BSE: 532488 | NSE: DIVISLAB | ISIN: INE361B01024 | Pharmaceuticals
 |
Cash Flow of Divis Laboratories |
------------------- in Rs. Cr. ------------------- |
| Mar '05 | Mar '06 | Mar '07 | Mar '08 | Mar '09 | ||||||
|
||||||||||
| 12 mths | 12 mths | 12 mths | 12 mths | 12 mths | ||||||
|
||||||||||
| Net Profit Before Tax | 102.31 | 106.91 | 226.70 | 384.69 | 458.34 | |||||
| Net Cash From Operating Activities | 37.89 | 49.89 | 189.68 | 302.11 | 315.51 | |||||
| Net Cash (used in)/from Investing Activities |
-26.32 | -112.29 | -158.87 | -235.48 | -232.11 | |||||
| Net Cash (used in)/from Financing Activities | -14.27 | 68.07 | -34.00 | -65.08 | -82.31 | |||||
| Net (decrease)/increase In Cash and Cash Equivalents | -2.70 | 5.68 | -3.19 | 1.55 | 1.09 | |||||
| Opening Cash & Cash Equivalents | 4.49 | 1.79 | 7.46 | 4.27 | 5.81 | |||||
| Closing Cash & Cash Equivalents | 1.79 | 7.46 | 4.27 | 5.81 | 6.90 | |||||
| ||||||||||
| Source : Religare Technova | ||||||||||
| Explore Divis Labs connections | ||||||||||
| ||||||||||
